News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Yan Meng

Articles by Yan Meng

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Could Scorpion Venom Component Play a Role in Glioblastoma Management?

Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma

How Dato-DXd and the TROPION Trials Are Transforming Solid Tumor Research

FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications

What Were The Most Impactful GU Oncology Data From ESMO 2025?

© 2025 MJH Life Sciences^®

All rights reserved.